Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
54.45 BRL | +6.83% |
|
+0.70% | +8.04% |
06-28 | Johnson & Johnson Reports 'Positive' Results in Late-Stage Myasthenia Gravis Trial | MT |
06-28 | J&J Unit's Rybrevant Combo Gets EU Approval | MT |
- Stock Market
- Equities
- JNJ Stock
- JNJB34 Stock
- News Johnson & Johnson
- Other languages